Objective: The aim of this study was to show, whether ATP sensitive K channels (K channels), are involved in the modulation of ATP norepinephrine (NE) release from the sympathetic nerves innervating the guinea-pig and human right atrium. Methods: The resting and release of NE, and also attenuated the evoked release at a single concentration (100 mM), and this latter action was also counteracted by glibenclamide (30 mM). Pinacidil, increased dose-dependently the resting and stimulation-evoked release of NE in a glibenclamidesensitive manner and reversed the inhibitory effect of cromakalim (100 mM), suggesting that it acts as an antagonist. Glibenclamide reduced the evoked release of [ H]NE, but these effects were not modified by glibenclamide (300 mM), indicating that neuronal adenosine (A ), adrenergic (a ) and muscarinic (M ) receptors do not act on K channels. In the human right atrium, cromakalim, and diazoxide 1 2 3 A T P 3 did not affect significantly the release of [ H]NE. However, glibenclamide (30-300 mM) and pinacidil (30-300 mM) enhanced dose-dependently the evoked-release of NE, and pinacidil also augmented the resting release. Conclusions: Our results indicate that 1 sympathetic nerve endings of the human and guinea-pig atrium are endowed with ATP-sensitive K channels. These channels responded to agonists and antagonists under the experimental conditions applied and they could modulate the release of NE thereby affecting the autonomic control of cardiac function under various physiological and pathophysiological conditions.
dial K channels, either by depletion of ATP as an Hungary) of 300 to 500 g body weight were lightly ATP endogenous trigger or by specific K channel openers, anesthetized with sevoflurane and then sacrificed by a blow ATP such as cromakalim or pinacidil, results in cardioprotection on the head, and the right atria were dissected. After during ischemia [8, 9] , while their inactivation by suldissection, the tissues were incubated for 40 min at 378C in phonylurea antidiabetics, such as glibenclamide worsens modified Krebs' solution containing 10 mCi / ml 1-(7,8)-
the recovery of post-ischemic contractile function [8] and [ H]norepinephrine (2.7?10 M, specific activity 37 Ci /
25
antagonizes A adenosine receptor-mediated cardioprotecmmol, Amersham) ascorbic acid (3?10 M) and 1 24 tion [10] [11] [12] . In addition to direct effect on myocardial Na EDTA (10 M) . The Krebs' solution was aerated 2 contractility, K channels are also involved in the with 95% O 15% CO throughout the experiment . To   ATP  2  2  3  3 regulation of coronary flow both by themselves and as a facilitate the uptake of H-norepinephrine ([ H]NE), the mediator of the vasodilator action of adenosine [13] .
preparations were stimulated during incubation at 1 Hz However, due to its complexity, the precise mechanism of with supramaximal (35 V/ cm) electrical field stimulation cardioprotection by K channels is not fully understood of 1-ms duration, through two platinum electrodes placed ATP yet [5, 7] . above and below the suspended atria, respectively. 3 Since ATP-sensitive potassium conductance is also After incubation, to remove excess [ H]NE, the atria present in neurons [5] , the possibility arises that the release were transferred to baths of 4 ml and were superfused at a of norepinephrine (NE) from sympathetic nerves supplying rate of 1 ml / min by a peristaltic pump for 90 min with the heart can be modulated via these channels which also Krebs' solution. Following a 90-min washout period, might affect cardiac function during physiological and superfusion was continued at the rate of 1 ml / min and pathophysiological conditions. It is well known that heart 3-min fractions of the superfusate were collected until the rate and myocardial contractility can be influenced by end of the experiment. Starting at the beginning of the 10th autonomic innervation. Sympathetic and vagal transmis-(S ), 28th (S ), 46th (S ) min, the preparations were 1 2 3 sion are in crosstalk: ACh released in response to ongoing stimulated electrically for 2 min at 2 Hz (240 stimuli). activity of the vagus is able to inhibit the release of NE Except for the stimulation rate, the method of stimulation from the nerve terminal, an effect mediated via Mwas the same as during incubation. Compounds to be 3 receptors located presynaptically in guinea-pigs [14, 15] investigated were added in perfusing Krebs' solution 6 min and in humans [16] . In addition, the release of NE is also after S , except for control experiments. , but no data are available on the modulation of NE A 1-ml aliquot of each collected fraction was transferred release. Adenosine, another cardioprotective modulator to scintillation vials containing 7 ml of scintillation fluid [19] , is able to inhibit NE release from sympathetic nerve (Echoscinti, National Diagnostics). The radioactivity of the in the heart, but not from the vagus, during normoxic [20] samples was measured in a scintillation beta specand hypoxic conditions [21] . Since adenosine is released in trophotometer (Tri-carb 4530, Packard Instrument). At the 3 excess during ischemia [22] , and part of its actions is end of each experiment, the residual H content of the atria mediated via K channels [12, 13, 23 ] the involvement of was determined. The tissue was kept overnight in 1 ml of ATP K channels in its presynaptic effects has also potential tissue solubilizer (Soluvable, NEN Research Product) at ATP 3 interest. room temperature, centrifuged and the H content of the Therefore, the main question addressed in this study sample was measured. The radioactivity of samples was was, whether the release of NE from the sympathetic expressed in terms of disintegrations per gram wet weight nerves of the guinea pig and human isolated right atrium of tissue (Bq / g). To normalize the quantity of radioactivity 3 taken from patients undergoing heart surgery is regulated released, the release of [ H]NE was expressed as a by K channels. In addition their possible interaction percentage of the total radioactivity present in the tissue ATP with the inhibitory neuromodulation by A -adenosine-, when the sample was collected (fractional release). [ H]NE [14] . The effect of drugs on the evoked release of tissues were perfused at a rate of 0.5 ml / min. After 60-min 3 preperfusion, the outflow was collected in 1.5-ml (3-min) [ H]NE was estimated as the FS / FS ratio compared to 3 2 fractions for an additional 60 min. During the collection the FS / FS ratio in the same experiment, which were 2 1 period, the preparations were stimulated electrically twice very similar in control experiments. Therefore, increase or at 60 V, 2 Hz, 1 ms impulse duration for 2 min (240 decrease of FS / FS over FS / FS indicates augmentation 3 2 2 1 pulses), as described above, during the 3rd and 13th or inhibition of stimulated NE release, respectively. The 3 collection periods (S and S ). Drugs were added at the effect of drugs on the resting release of [ H]NE was 1 2 8th fraction to the perfusion fluid and they were mainassessed as the FR / FR ratio compared to FR / FR ratio 2 1 3 2 tained till the end of the experiment. At the end of the in the same experiments, where FR , FR and FR are the 1 2 3 perfusion period, the tissues were removed from the release measured during the prestimulation sample of the perfusion chamber and suspended in 500 ml of 10% correspondent stimulation (S , S and S ). used. A value of P,0.05 was considered to be significant. mitral valve replacement (three patients) and graft interposition of the ascending aorta (one patient). The daily 2.5. Drugs medication with digitalis, diuretics, antiarrhytmic drugs, 3 glyceryl trinitrate, antihypertensive drugs and b-blocking
The following drugs were used: 1-(7,8)-[ H]norepinepagents was continued until the cardiac operation. Standard hrine (specific activity 37 Ci / mmol; Amersham), premedication (diazepam1flunitrazepam), induction anescromakalim, oxotremorine (SIGMA), adenosine, diazoxthesia (oxygen1nitrous oxide, fentanyl, dehydrobenide, glibenclamide, clonidine, 5-hydroxidecanoate and zperydol) and muscle relaxation (pipecuronium) were pinacidil (RBI). Cromakalim and glibenclamide was disemployed. No drugs that can influence tissue catecholsolved in DMSO (0.3-0.6%), pinacidil and 5-hydroxamine stores were used, nor was catecholamine support idecanoate were dissolved in 2-hydroxypropyl-b-cyclodexgiven. The resection specimen from right atrial muscle was trin (RBI). Control experiments were performed in the excised and were placed in bubbled (95% O -5% CO ) presence of drug-free solvents, using identical conditions 2 2 Krebs' solution immediately and kept there during the applied for drug application. transport period (30-40 min) at 10-178C.
The composition of the modified Krebs' solution was After removal and transportation the tissue was cut into (mM): NaCl 113; CaCl 1.4; KCl 4.7; KH PO 1.2; 2 24 8-12 mg pieces and incubated in 1 ml of modified Krebs NaHCO 25; MgSO 0.9; and glucose 11.5. tected only in a single concentration (100 mM) ( Fig. 2A) . Student's t-test.
Pinacidil, which is also known as a K channel ATP opener, interestingly did not reduce, but increased dosedependently the basal and stimulation-evoked release of NE (Figs. 3A and B) . In the presence of glibenclamide (300 mM) pinacidil (100 mM) was unable to further and 2.1860.18 in the presence of cromakalim and increase the evoked release of NE (Fig. 3A) . Furthermore, cromakalim1pinacidil, respectively (n54, P,0.01). These at a concentration of 300 mM, it antagonized the inhibitory findings indicate that pinacidil acts on neuronal tissue effect of cromakalim (100 mM), a K channel opener on (sympathetic axon terminal) as an antagonist; preventing ATP evoked release of NE: the FS / FS ratios were 0.8260.02 the effect of an agonist (cromakalim) and competing with (Figs. 4A and B) . These effects were also concentrationSince it is well established that the release of NE is dependent between 30 and 300 mM, and the maximal subjected to presynaptic modulation by endogenous ligeffect obtained by 300 mM, glibenclamide, which resulted ands, via stimulation of receptors expressed on noradrenerin a more than 150% increase of the evoked release.
gic terminals [14] [15] [16] [17] 20 ], we also studied whether the 5-Hydroxidecanoate (5-HD), which is known as another, inhibitory effect of adenosine, oxotremorine or clonidine structurally unrelated inhibitor of K channels, was also can be antagonized by inhibition of K channels. Adeno-
examined on resting and stimulation-evoked NE release. sine (30-300 mM) decreased the evoked release of H in a However, 5-HD (100 mM), did not affect significantly the concentration dependent manner and the maximum inhibiresting and stimulation-evoked release of NE under our tion that could be achieved with adenosine (300 mM) was experimental conditions, the FR / FR and FS / FS ratios 34%, which is in agreement with that obtained by earlier The uptake of radioactivity in the human right atrium was applied to perfusion medium 15 min before S . The release of tritium 6 Table 1 channel antagonist was able to increase the evoked release used in other neurotransmitter release studies using K ATP channel ligands (see e.g. the paper Takata et al. [24] ). (Table 1) . On the other hand, glibenclamide (30-300 mM), density and distribution are different in these preparations and pinacidil (30-300 mM) enhanced dose-dependently which might be responsible for the discrepancy; (ii) the the evoked release of NE, showing that the release of NE effect of agonists (cromakalim, diazoxide) could be prein human right atrium could also be controlled by K vented by relatively low concentration of glibenclamide ATP channel modulators, however, the maximal effect, which (30 mM). was reached at 300 mM concentration was less than
In addition to antagonism of the effect of cromakalim, obtained in the guinea-pig preparation (Table 1, Fig. 6 ). In diazoxide and pinacidil, glibenclamide by itself powerfully addition pinacidil, but not glibenclamide (Table 1) inenhanced the resting and stimulation-evoked release of creased also the resting release of tritium.
NE. Although originally was regarded as a specific K ATP channel antagonist, recent observations indicate that glibenclamide can cause effects, unrelated to K channel ATP 4. Discussion blockade, and a part of these effects may also influence neurotransmitter release [25] . In fact glibenclamide has In this study, the modulation of NE release from been shown to affect other ionic conductances present on inhibitors was studied in the isolated, superfused right dent K current [26] and Ca activated K current [27], atrium of the guinea-pig and in isolated human right atrium which may also account for the increase in NE release. obtained from cardiovascular surgery specimen. Out of the Furthermore it also has impact on metabolic processes e.g. K channel openers, cromakalim and diazoxide reduced it blocks mitochondrial K channels [28] , as well as ATP ATP 3 the stimulation-evoked release of [ H]NE, and their effects 59-nucleotidase enzyme [29] , involved in purine metabocould be antagonized by glibenclamide, the specific K lism. In the lack of selective pharmacological tools it is ATP channel antagonist suggesting that sympathetic nerve difficult to elucidate whether any of these actions do terminals supplying the cardiac tissue of the guinea-pig are contribute to the enhancement of NE release by glibenequipped with K channels and the release of NE is clamide. Nevertheless, the effect of another K channel ATP ATP subject to modulation by these channels. In our experiinhibitor, 5-HD was also tested. 5-HD has been widely ments, the maximal inhibitory effect obtained by K used to block ischemia-selective activation of K chan-ATP ATP channel openers i.e. by cromakalim and diazoxide was nels in cardiovascular research [30] : it is regarded to be a relatively small¯20%, whereas glibenclamide, the K structurally unrelated, but more specific blocker of K channels than glibenclamide. However, 5HD did not alter heteroreceptors [41] ; noradrenergic nerve terminals are the resting and the stimulation-evoked release of NE equipped with inhibitory A -adenosine and M -muscarinic 1 3 indicating that the effect of glibenclamide to increase NE receptors and a -autoreceptors [14] [15] [16] [17] 20 by pinacidil, on rat brain cortical slices and augmentation these specimens. However, the effect of pinacidil and of NE release by pinacidil from the rabbit pulmonary glibenclamide was also relatively moderate in the human artery [33] and guinea-pig and rabbit mesenteric arteries tissue in comparison to the guinea pig right atrium, which [34] was also reported. In our experiments pinacidil was may reflect to the different density of K channels on the ATP unable to further increase the release of NE in the presence sympathetic nerves of the human and guinea pig heart. of glibenclamide and it also prevented the inhibitory effect Finally one has to bear in mind that the human atrial tissue 3 of cromakalim on evoked [ H]NE release indicating that it was obtained not from healthy population but from inis able to bind to K channels, probably as an antagonist. dividuals bearing serious cardiovascular disease, and im-ATP This paradoxical effect of pinacidil on NE release indicates paired cardiac function. the pharmacological heterogeneity of the K channels Our observations has some important pathophysiological ATP located on nerve terminals, vascular smooth muscle, and and clinical implications. It is widely accepted that aupancreatic b-cells: opposite from diazoxide and tonomic innervation of the heart is an important regulatory cromakalim, pinacidil did not inhibit, but increased NE mechanism, which modulates cardiac function upon a release in our study, and in others [24, 33, 34] ; in contrast, variety of pathological situations. It is also well known that pinacidil exert inhibitory effect on vascular smooth muscle the natural activity of K channels are regulated by ATP contraction [35, 36] and on insulin secretion [37] [2, 42] . When intracellular energy stores are depleted, the tissue has been recently revealed by molecular biological blockade of K channels is relieved and inactive chan-ATP studies, offering a structural basis for pharmacological nels are activated. Therefore, K channels provide an ATP heterogeneity [38] . Furthermore, the action of pinacidil to endogenous protective mechanism, which could play a role increase NE release from sympathetic nerves supplying the during metabolic stress, hypoxia, hypoglycemia and isheart corroborates with the tachycardia, a frequent side chemia. Decreased release of NE under these conditions effect, observed in preclinical studies using pinacidil [39] might result in a drop in heart rate and protection of and provide direct support for the recent observations on myocardium. However, one has to take into account that the mechanism of proarrhytmogenic effect of pinacidil in during ischemia, in addition to exocytotic release, a 21 the isolated guinea-pig heart [40] . massive release of NE occurs in a Ca -independent It is well established that the release of NE in the right fashion [43, 44] , which may overshadow the reduction of atrium is modulated by prejunctional auto-and exocytotic release. In addition, K channels are also 
